Volume | 6,539,697 |
|
|||||
News | - | ||||||
Day High | 90.75 | Low High |
|||||
Day Low | 89.28 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
SPDR S&P Biotech | XBI | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
90.63 | 89.28 | 90.75 | 89.70 | 90.59 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
86,192 | 6,539,697 | 89.76 | 586,989,345 | - | 63.80 - 103.52 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
20:00:00 | 183,197 | 89.70 | USD |
SPDR S&P Biotech (XBI) Options Flow Summary
SPDR S&P Biotech Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.95B | 77.43M | - | 18.32M | 733.48M | 9.47 | 9.47 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News SPDR S&P Biotech
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
XBI Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 91.21 | 95.40 | 89.28 | 92.56 | 7,624,167 | -1.59 | -1.74% |
1 Month | 91.86 | 95.40 | 86.98 | 91.13 | 8,276,458 | -2.24 | -2.44% |
3 Months | 93.88 | 95.885 | 81.14 | 89.29 | 9,820,157 | -4.26 | -4.54% |
6 Months | 85.31 | 103.52 | 81.14 | 91.05 | 10,668,973 | 4.31 | 5.05% |
1 Year | 87.34 | 103.52 | 63.80 | 84.12 | 9,604,593 | 2.28 | 2.61% |
3 Years | 132.92 | 141.50 | 61.78 | 87.87 | 9,721,625 | -43.30 | -32.58% |
5 Years | 86.32 | 174.79 | 61.78 | 93.68 | 8,103,214 | 3.30 | 3.82% |
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). |